Photodynamic Therapy: Recent Progress and Development
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: closed (31 October 2024) | Viewed by 6049
Special Issue Editors
Interests: laser spectroscopy of complex molecular systems; laser applications in life sciences, including medical applications; optics and spectroscopy of micro-/nanodroplets; drug delivery systems; study of colloidal systems (drug compounds in colloidal formulations); microfluidics; optofluidics; optical techniques for detection/monitoring/removal of environmental pollutants
Special Issues, Collections and Topics in MDPI journals
Interests: laser spectroscopy of complex molecular systems; spectroscopic analyses of biomolecules and colloids; biophysics; microfluidics; colloids and interfaces; microbiology (MIC, MBC, antimicrobial synergy tests) and laser applications in biomedical sciences
Special Issues, Collections and Topics in MDPI journals
Interests: lasers; spectroscopic techniques for the investigation of pollutants and intermediate species formed in combustion processes; gas-phase laser spectroscopy of astrophysically relevant molecules; photophysics and photochemistry of compounds of interest in photodynamic therapy; nanocompounds for targeted drug delivery; lasing of microdroplets; spectroscopic techniques; steady-state absorption and excitation/emission fluorescence; FTIR; LIF; CRDS; Raman; LIBS; flash photolysis; time-resolved singlet oxygen phosphorescence
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Photodynamic Therapy (PDT) is based on light-induced activation of photosensitizers (PS) leading to generation of Reactive Oxygen Species (ROS) which mediate targeted cell destruction. PDT has received extensive attention owing to its recognized advantages like high selectivity, minimally invasive nature, and limited side effects.
Currently, research for new or improved radiation sources, irradiation protocols, and novel PSs are developed for improving the therapeutic effect.
PDT has already been approved by the FDA/EMA for the treatment of different malignancies (skin, bladder, lung, prostate, and oesophagus cancers) or precancerous tumours (actinic keratoses), as well as non-malignant diseases (macular degeneration). Several PSs are under consideration by authorities in oncologic PDT and numerous clinical trials are now in progress. The application of PDT is also being explored for the cure of cardiovascular, ophthalmology, dermatology, urology, and infectious diseases.
This Special Issue invites both reviews and original research papers dealing with the recent progress in development of innovative solutions for PDT. You are welcome to submit studies implying but not limited to the following topics:
- Design, synthesis, and characterization of new biocompatible and biodegradable PSs; nano-complexes and formulation;
- Photobactericidal, sono-photodynamic, theragnostic agents;
- New approaches of PDT in biomedicine;
- Preclinical and clinical applications.
Dr. Adriana Smarandache
Dr. Andra Dinache
Dr. Angela Staicu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- photodynamic therapy
- anticancer
- photosensitizers
- nanomaterials
- photodiagnosis
- theragnostic
- antimicrobial
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.